Can the use of cancer drugs really provide Alzheimer’s help? New medical research says yes.
According to new studies published in the Journal of Science Advances (performed by an international team of researchers) found that cancer therapy may help with Alzheimer’s dementia prevention.
The drug is called “bexarotene.” Researchers discovered that bexarotene may target the initial symptoms of Alzheimer’s disease (AD) that results in brain cell death.
During the research study, it was noted that after symptoms of AD begin, bexarotene was NOT effective in halting symptoms. However, when the drug was administered in worms before they were genetically modified to develop AD, the worms did not go on to develop the disease.
According to Professor Michele Vendruscolo, senior author of the study, “The body has a variety of natural defenses to protect itself against neurodegeneration, but as we age, these defenses become progressively impaired and can get overwhelmed. By understanding how these natural defenses work, we might be able to support them by designing drugs that behave in similar ways.”
More studies are required in order to positively target the level of effectiveness of cancer fighting drugs such as bexarotene in the fight against Alzheimer’s disease.
Learn more about the latest research in treatment for Alzheimer’s disease and Alzheimer’s prevention by CLICKING HERE to join our 25 lesson course for caregivers today at Alzu.org.
